Mass Medicaments India Private Limited - Company Profile

It is a business services private limited company based in Chennai, Tamil Nadu, India, established in 2009.
2009 Chennai, Tamil Nadu, India Struck Off
Last Updated:
Access Report
About Mass Medicaments India Private Limited

Mass Medicaments India Private Limited, a struck off private limited company, was established on 30 January 2009 in Chennai, Tamil Nadu, India. Engaging in other services within the business services sector, it holds CIN: U74999TN2009PTC070632. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Akila Rajasekaran (Director), Job Rajasekaran Ponnusamy (Director). Past directors included Ganesan Krishnamurthy. It is based at 245, Peters Road Gopalapuram, Chennai, Tamil Nadu, 600086.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TN2009PTC070632

  • Registration Number

    070632

  • Incorporation Date

    30 January 2009

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 17 Year, 1 Month
Company report

Mass Medicaments India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mass Medicaments India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mass Medicaments India Private Limited?
Current Directors
Name Designation Appointment Date Status
Akila Rajasekaran Director 30 Jan 2009 Current
Job Rajasekaran Ponnusamy Director 30 Jan 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 May 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mass Medicaments India.

Enhance accessibility to Mass Medicaments India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Mass Medicaments India revenue growth over time
Mass Medicaments India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mass Medicaments India?

Unlock access to Mass Medicaments India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Mass Medicaments India?

Unlock and access historical data on people associated with Mass Medicaments India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mass Medicaments India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mass Medicaments India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mass Medicaments India
Recent Activity within the Organization
  • Director Appointment

    Progress on Akila Rajasekaran was appointed as a Director was appointed as a Director on 30 Jan 2009 & has been associated with this company since 17 years 1 month . was documented.

  • Director Appointment

    Job Rajasekaran Ponnusamy was appointed as a Director was appointed as a Director on 30 Jan 2009 & has been associated with this company since 17 years 1 month . was recorded as a recent event.

  • Company Incorporation

    Mass Medicaments India Private Limited was registered on 30 Jan 2009 with Roc Chennai & aged 17 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mass Medicaments India Private Limited?

The CIN of Mass Medicaments India Private Limited is U74999TN2009PTC070632.

Where is Mass Medicaments India Private Limited headquartered?

Mass Medicaments India Private Limited is headquartered at 245, Peters Road Gopalapuram, Chennai, Tamil Nadu, 600086.

When was Mass Medicaments India Private Limited incorporated?

Mass Medicaments India Private Limited was incorporated on 30 January 2009.

Who are the current directors of Mass Medicaments India Private Limited?

The current directors of Mass Medicaments India Private Limited are

What is the primary industry of Mass Medicaments India Private Limited?

The primary industry of Mass Medicaments India Private Limited is Business Services.

Is Mass Medicaments India Private Limited a listed company?

Mass Medicaments India Private Limited is unlisted.

What is the capital structure of Mass Medicaments India Private Limited?

The authorized capital of Mass Medicaments India Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available